Lin Elizabeth Yeu
SEC CIK 1842190 · EDGAR
BoughtSold
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-09 16:13 | 2026-09-04 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $87.50 | -10.8K | 2,547 | -81% | -$942.6K |
| MTI | 2026-09-09 16:13 | 2026-09-04 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $87.50 | -3,180 | 1,590 | -67% | -$278.2K |
| MT | 2026-09-03 16:29 | 2026-09-01+ | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $77.17 | -9,988 | 13.3K | -43% | -$770.8K |
| TI | 2026-09-03 16:29 | 2026-09-02 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $80.00 | -1,590 | 4,770 | -25% | -$127.2K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $68.36 | -1,144 | 23.3K | -5% | -$78.2K |
| D | 2026-03-17 | 2026-03-15 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | M - OptEx | — | +2,511 | 24.5K | +11% | — |
| D | 2025-12-17 | 2025-12-16 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale+OE | $79.50 | -2,078 | 21.9K | -9% | -$165.2K |
| D | 2025-12-17 | 2025-12-15 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | M - OptEx | — | +6,819 | 24.0K | +40% | — |
| D | 2025-06-17 | 2025-06-13 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | M - OptEx | — | +3,350 | 8,700 | +63% | — |
| D | 2025-06-17 | 2025-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Chief Medical Off | S - Sale+OE | $41.08 | -1,006 | 7,694 | -12% | -$41.3K |
| D | 2024-06-25 | 2024-06-24 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Dir | M - OptEx | — | +3,350 | 5,350 | +168% | — |
| D | 2024-06-24 | 2024-06-20 | STAA | STAAR SURGICAL CO | Lin Elizabeth Yeu | Dir | A - Grant | $0.00 | +2,244 | 5,099 | +79% | $0 |
| 2023-09-22 | 2023-09-21 | STAA | STAAR SURGICAL CO | Lin Elizabeth Yeu | Dir | P - Purchase | $40.00 | +2,500 | 2,855 | +704% | +$100.0K | |
| I | 2023-08-17 | 2023-08-15 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Dir | P - Purchase | $16.80 | +9,506 | 15.9K | +149% | +$159.7K |
| D | 2023-06-21 | 2023-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Dir | M - OptEx | — | +2,000 | 2,000 | New | — |
| MI | 2022-09-16 | 2022-09-14 | TARS | Tarsus Pharmaceuticals, Inc. | Lin Elizabeth Yeu | Dir | P - Purchase | $16.12 | +18.4K | 6,360 | New | +$296.6K |
| D | 2022-06-17 | 2022-06-16 | STAA | STAAR SURGICAL CO | Lin Elizabeth Yeu | Dir | M - OptEx | $0.00 | +355 | 355 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations